뉴스

• [K-Bio Pulse]Biotech Stocks Defy 'Black Tuesday' as MedPacto Soars, Bioinfra Faces Dead... Despite the "Black Tuesday" selloff on July 28, several biotech stocks bucked the broader market. As the Kosdaq tumbled, Cellid, Bioinfra, and MedPacto all hit www.edaily.co.kr · 2026.07.29
• Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse] The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended www.edaily.co.kr · 2026.07.14
• BL Pharmtech Shares Hit Upper Limit as Expectations Grow for Technology Transfer Deal[K-Bio Pulse... On June 18, shares of BL PharmTech, JLK, and Raphas stood out in the domestic pharmaceutical and biotechnology stock market with strong gains. In particular, BL www.edaily.co.kr · 2026.06.21